Presentation will showcase the novel mechanisms of degradation of Amphista's Targeted Glues™, which recruit diverse E3 ligases, including DCAF16 and FBXO22, expanding the diversity and opportunity for ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will report third ...

Zag Bio™, Inc., a biotechnology company pioneering thymus-targeted medicines, today announced the company’s launch with $80 million in financing, including a recently closed Series A financing.

AM ET Participant Dial-In (U.S.): 1-877-407-9039 Participant Dial-In (International): 1-201-689-8470 Webcast Access: Please click here The live and archived webcast can also be accessed by visiting ...

Ole Henrik Bang-Andreasen added: “Joining the PL BioScience (PLB) board is bittersweet with the passing of my colleague and mentor Reinhard Vogt. Taking the baton from Reinhard, I am looking forward ...

Live webcasts will be available on the Investor Relations section of the Company’s website at www.entradatx.com. Replays will be available on the Entrada website for 90 days following the events.

AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board Brings substantial expertise in development of first-in-class disease-modifying therapies in dementia ...

Tonix Pharmaceuticals Holding Corp.* Tonix Pharmaceuticals is a fully-integrated biotechnology company with marketed products and a pipeline of development candidates. Tonix has received FDA approval ...

RIYAD, Arabie saoudite, 28 oct. 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre a annoncé qu’il ouvrirait la première usine d’Arabie saoudite pour la fabrication de thé ...